Established, growing, unique biotech company is seeking outstanding candidates to join their team! Multiple openings available.
? This position will be responsible for cleaning and sterilizing labware, maintaining labware inventor [...]
Abbott, the healthcare giant based near Chicago, IL, has acquired Topera, a venture-backed startup founded on diagnostic technology developed by a San Diego cardiologist to pinpoint the electrical…
[[Click headline to continue reading.]]
GMP Pharmaceutical or Biotech manufacturing environment. Monitors program execution to ensure compliance with federal, state and local regulations….
From Genentech – 30 Oct 2014 18:37:43 GMT
– View all Oceanside jobs
Our client, a leading developer of hardware and software platforms in the biotech space, is seeking a qualified Sr….
From Lab Support – 30 Oct 2014 18:10:55 GMT
– View all San Diego jobs
GRCh38 (or hg38) is the latest human genome assembly, which was released almost a year ago. MyGene.info is now moved to support GRCh38 by default for human genes, but the data (including queries) based on previous assembly version (GRCh37/hg19) are still supported. Here are some details about this change:
Imagine a zombie costume. You probably see – pale, bloody makeup, ripped clothes, dead-eyed stare. All of that preparation, however, would not be convincing if the zombie were to just move around normally. In fact “Walking Dead” special effects artist/director Greg Nicotero teaches a school on how to lumber around like a zombie for […]
JOB #: 114653-T
Join this innovator in medical electronics. My client develops, manufactures and markets point of care blood analysis systems to include blood gas analysis, transcutaneous monitoring and immunoassay testing. The ideal candidate will [...]
PROJECT ANALYST / RESEARCH ASSOCIATE Simply Biotech specializes in recruiting exclusively for San Diego’s biotech commun … / Research Associate for a leading and growing San Diego biotech firm. The Project Analyst is responsible for…
IRVINE, Calif., Oct. 30, 2014 /PRNewswire/ – Irvine Pharmaceutical Services, Inc., a leading provider in cGMP contract development and parenteral manufacturing services, announces plans to open a new facility in Hangzhou, China. This 115,000sqft. newly built, state-of-the-art facility will expand Irvine’s service offerings into the Asian markets.
Irvine’s newest facility is scheduled to be fully operational in the first quarter of 2015. CEO and Founder, Dr. Assad J. Kazeminy explains, “Irvine is responding to the rising needs of large multi-national pharmaceutical companies that are looking for contract organizations overseas that include robust cGMP quality infrastructure and technical expertise. Irvine will now have a local presence and a strong understanding of the local market to offer the region high quality analytical support.”
Learn more about Irvine’s expansion into the Asian market – Visit us at booth 3110 at the 2014 AAPS Annual Meeting and Exposition in San Diego, CA on November 2 – 6, 2014.
Irvine Pharmaceutical Service Inc. is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine provides cGMP contract development and manufacturing services such as parenteral manufacturing (liquid and lyophilized), preformulation/formulation development, analytical development, biopharmaceutical development, stability storage, analytical chemistry, structural chemistry, microbiology, and drug delivery device testing.
Learn more at www.irvinepharma.com or call (949) 951-4425.
SOURCE Irvine Pharmaceutical Services, Inc.